
Thomas H. Kean Jr.
RHouseRepresentative · New Jersey
Bought up to $15,000 of Abbott Laboratories (ABT)
Trade dated Jan 29, 202621 days to disclose
ABT since the buy
-14.4%
S&P 500, same window
+9.1%
▼ ABT trailed the S&P 500 by 23.5 points since the buy
Price move from the trade date's close to the most recent close. A buy is favorable when the stock rose after.
⚑ Committee jurisdiction
Thomas H. Kean Jr. sits on Energy and Commerce, which oversees the Healthcare sector. This trade fell in that sector while Thomas H. Kean Jr. held the seat. STOCK Act trades are legal; this is a structural overlap on the public record.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Dec 10, 2025CommitteePutting Families First: Strengthening CHAMPVA for Survivors and Dependents
- Dec 17, 2025Floor voteResult: Passed
- Dec 18, 2025Floor voteResult: Failed
- Dec 18, 2025Floor voteResult: Passed
- Jan 14, 2026CommitteeOversight of the Federal Communications Commission
- Jan 15, 2026LegislationHealthcare sector
- Jan 22, 2026LegislationHealthcare sector
- Jan 29, 2026TradeBought up to $15,000 of ABT
- Jan 30, 2026LegislationHealthcare sector
- Feb 2, 2026Floor voteResult: Passed
- Feb 3, 2026LegislationHealthcare sector
- Feb 3, 2026Floor voteResult: Passed
- Feb 9, 2026LegislationHealthcare sector
- Feb 19, 2026DisclosureDisclosed the tradePublic filing
- Mar 5, 2026CommitteeHidden Wounds: Effectively Supporting Veterans with TBI
Get an alert the moment Thomas H. Kean Jr. files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.